http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
MAX Power raises $3.75 million from warrant exercise, schedules shareholder vote
-
Belden prices $1.85 billion term loan to fund RUCKUS acquisition
-
Hilton Grand Vacations completes $300 million securitization
-
Class 1 Nickel completes private placement and debt-to-equity conversion
-
Guardant Health receives FDA approval for companion diagnostic test
-
PharmaEssentia acquires Canadian partner FORUS for $36.5 million
-
Mega Matrix addresses unusual trading activity in shares
-
Merck Animal Health to acquire poultry technology firm TARGAN
-
VERAXA Biotech completes merger, begins NASDAQ trading
-
Vishay extends automotive ferrite bead series with smaller sizes
-
Guerrilla RF launches GRF5847 power amplifier with 35+ dBm output
-
Virginia American Water settles for $16 million rate increase
-
Trade Desk adds former Warner Bros. Games president to board
-
Rubrik launches second season of cybersecurity podcast on North Korea threats
-
Worksport CEO receives $50,000 in stock instead of cash compensation
-
Rubrik unveils Annapurna to process unstructured data for AI applications
-
Rubrik partners with six global systems integrators for AI security platform
-
Rubrik launches agent security cloud for Anthropic's Claude code
-
Rubrik launches autonomous recovery solution for cloud apps
-
Rubrik acquires Strata.io to enhance identity security capabilities
-
Rubrik launches AI agent platform for automated cyber resilience
-
Jet.AI reviews options for SpaceX equity stake amid reported IPO plans
-
Nasus Pharma Announces Positive Results from Preclinical Pharmacokinetic and Safety Study of Intranasal Ondansetron
-
Victory Capital reports total client assets of $342.4 billion for may
-
Soluna reports May 2026 operations across data center projects
-
TG Therapeutics reports positive phase 1 data for BRIUMVI in myasthenia gravis
-
AST SpaceMobile schedules BlueBird satellites 8-10 launch for june 17
-
Personalis gets CE-IVD marking for blood collection kits in Europe
-
Interactive Brokers offers commission-free BlackRock ETFs in Europe
-
Zai Lab wins China approval for cervical cancer drug TIVDAK
-
Seaport Therapeutics reports positive phase 1 data for GlyphAgo anxiety drug
-
Gilead and Merck announce successful HIV treatment trial results
-
Merck and Gilead discontinue lung cancer drug combination trial
-
HII partner launches manufacturing line for ROMULUS unmanned vessels
-
MAX Power sells lithium project to Homeland for $1.1 million stake
-
EraNova Metals closes oversubscribed private placement for $627,525
-
Ainos reports 499% revenue growth in 2025, expands AI scent technology
-
Pacific Ridge increases private placement to C$8.2 million
-
Marvel Biosciences receives Australian patent allowance for MB-204
-
Ionis appoints Ludwig Hantson to board of directors
-
Red White & Bloom subsidiary completes Ayurcann acquisition
-
BioGene Therapeutics appoints Ty Howton to board of directors
-
Ingredion announces $5 billion acquisition of Tate & Lyle
-
Ingredion to acquire Tate & Lyle for $5 billion in all-cash deal
-
Functional Brands receives interest from partners for gold tokenization platform
-
Securitize merger with CEPT gets SEC approval, shareholder vote set for June 29
-
Union Pacific announces death of former CEO Dick Davidson at 84
-
Ainos expands AI Nose platform into hospital emergency departments
-
Walmart shareholders approve all company proposals at annual meeting
-
Eledon to present islet transplant trial data at diabetes conference
